month journal clinical psychiatry lead article medication guidelines adults major depressive disorder apparent function florida medicaid drug therapy management program behavioral health hard imagine title inappropriate terms psychiatrists medications least i read title article florida best practice psychotherapeutic medication guidelines fpg adults major depressive disorder little insight i difficulty treatment medications psychotherapy psychotherapy almost always needs accompany medication treatment one level intensity another providing medication alone psychotherapy important distinction one common misconceptions medication solve common life problems like interpersonal problems work home second issue idea medication management one colleagues used say pharmacists manage medications treat patients term also anathema psychiatrist around billing coding guidelines invented term came mean minute appointment reduced psychiatric treatment brief discussion medication two lowest reimbursement codes coding scheme handily allowed psychiatric treatment split rest medicine reimbursed lower rate finally term behavioral health long standing business term indicate managed care environment business supervision rather mental health environment psychiatric supervision terms suggest managed care companies government guidelines psychiatrists sure enough looking partners project majority behavioral health organizations managed care companies followed closely government organizations associations three psychiatry departments organizations article describes process result multistakeholder florida expert panel stakeholder word always makes me cringe whenever i seen medicine psychiatry nothing good ever come two stakeholders medical treatment physicians patient i stretch family still actively involved i want see anybody else room authors detail rationale yet another guideline state notwithstanding public health priority mdd well increasing public academic policy attention given mdd misdiagnosis delayed diagnosis failure incorporate appropriate measurement based care significant modifiable deficiencies current practice true state widespread phq screening screening tool suddenly becomes diagnosis measurement based care suddenly becomes collection meaningless cross sectional scores clinics state listing diagnosis mdd real life worked like intensive clinical trials prove hypothesis go list several reason guideline cite american psychiatric association apa guideline conflation empirical evidence expert consensus suggesting nothing sacred expert consensus patients seen experts may patients seen physicians suggest guidelines derived pharmacological trials may limited suggesting may limited generalizability due trail designs conditions rule certain conditions discuss problems experimental design discuss limited long term follow measurement functional capacity limiting factors given authors really intend correct criticisms difficult see rationale new guideline instead say consensus process overarching principle writing fpg along providing guidance especially primary care physicians provide safe effective treatment depression authors use hierarchical approach tiers treatment without using algorithm level initial treatment levels basically used initial levels treatment ineffective tolerated surprises psychiatrist used treating depression especially referrals primary care physicians given stated concerns biasing effects clinical trials sponsored pharmaceutical companies specific fda indications many qualifiers addition atypical antipsychotic approved major depressive disorder ie aripriprazole brexpiprazole level level basically failure level antidepressant monotherapy fairness switching another antidepressant monotherapy level suggested option clear concern authors second generation antipsychotics scheme metabolic rather neurological side effects i found significant number neurological side effects aripiprazole including parkinson syndrome akathisia tardive dyskinesia medications nowhere paper diagnostic skills listed important physicians emphasis measurement based care rating scales drug induced neurological disorders question safer augmentation strategies discussed regard issue weight gain medication side effect strategy listed select medications low relative risk weight gain metabolic syndrome couple related issues come including fact significant number patients walk clinic high bmi treatment depression diagnosis obesity metabolic syndrome made managed along depression patients gain significant weight either aripiprazole brexpiprazole definitely exist clinicians developed successful strategies using atypical antipsychotics minimal weight gain also common problems insomnia associated depression resolve antidepressant therapy significant anxiety without panic attacks major depression psychotic features major depression mixed features discussed important variants special interventions commonly used primary care included like electroconvulsive therapy transcranial magnetic stimulation tms acknowledged lack patient acceptance availability treatments might result using various medication combinations may less effective vagal nerve stimulation recommended level treatment i serious reservations effective anyone fpg i would expect collection stakeholders listed representatives managed care companies rather stakeholders rehash strategies around years opportunity design comprehensive system care patients depression evidence happened reason people go psychiatry reasons bode well assumption everyone system comprehensive assessments like psychiatrists system mental health care designed stakeholders could possibly develop state art resources neuromodulation tms deep brain stimulation sleep studies monitoring cognitive effects depression antidepressants detoxification addiction treatment reasonable inpatient residential resources system would designed timely assessments difficult problems like mdd psychosis psychiatrists adequate numbers psychotherapists pilot programs looking computerized cognitive behavior therapy sleep depression anxiety would useful one two crisis oriented sessions specific orientation blanket statement utility evidence based psychotherapies without adequate numbers therapists carry helpful way need system redesign stakeholders stakeholders making guidelines pretending know something quality george dawson md dfapa synopsis certain stakeholders system money power sophisticated electronic health records set administrative clinical purposes may obligation design system optimize care rather telling people delivering care poorly integrated system rationed resources applying strategies already well known references mcintyre rs suppes tandon r ostacher mj florida best practice psychotherapeutic medication guidelines adults major depressive disorder clin psychiatry jul ostacher mj tandon r suppes florida best practice psychotherapeutic medication guidelines adults bipolar disorder novel practical patient centered guide clinicians clin psychiatry jul doi jcp cs pubmed pmid gartlehner gaynes bn amick hr asher gn morgan lc coker schwimmer et al comparative benefits harms antidepressant psychological complementary exercise treatments major depression evidence report clinical practice guideline american college physicians ann intern med doi qaseem barry mj kansagara clinical guidelines committee american college physicians nonpharmacologic versus pharmacologic treatment adult patients major depressive disorder clinical practice guideline american college physicians ann intern med doi